Valacyclovir hydrochloride and E.e.s. 200 drug interactions - a phase IV clinical study of FDA data
Summary:
We study 12,929 people who take Valacyclovir hydrochloride (valacyclovir hydrochloride) and E.e.s. 200 (erythromycin ethylsuccinate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Valacyclovir hydrochloride and E.e.s. 200. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Valacyclovir hydrochloride?
Valacyclovir hydrochloride has active ingredients of valacyclovir hydrochloride. It is often used in herpes zoster. eHealthMe is studying from 12,929 Valacyclovir hydrochloride users. Check the latest studies of Valacyclovir hydrochloride.
What is E.e.s. 200?
E.e.s. 200 has active ingredients of erythromycin ethylsuccinate.
No report is found.
Do you take Valacyclovir hydrochloride and E.e.s. 200?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Valacyclovir hydrochloride (12,929 reports)
- E.e.s. 200
How the study uses the data?
The study uses data from the FDA. It is based on valacyclovir hydrochloride and erythromycin ethylsuccinate (the active ingredients of Valacyclovir hydrochloride and E.e.s. 200, respectively), and Valacyclovir hydrochloride and E.e.s. 200 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Hyzaar cause Transitional Cell Carcinoma? - 4 seconds ago
- Could Etomidate cause Cardiomyopathy? - 6 seconds ago
- Drug interactions of Aspirin and Dimethyl Fumarate - 10 seconds ago
- Lorazepam and Hypotension for Men aged 60+ - 11 seconds ago
- Lorazepam and Low Blood Pressure for Men aged 60+ - 11 seconds ago
- Lorazepam and Blood Pressure Decreased for Men aged 60+ - 11 seconds ago
- Drug interactions of Exemestane and Dexamethasone Sodium Phosphate - 17 seconds ago
- Hair Loss in Claritin, how severe and when it was recovered? - 17 seconds ago
- Drug interactions of Melatonin and Tepezza - 24 seconds ago
- Could Motrin cause Serositis? - 27 seconds ago